Miniaturization and Automation of a Human In Vitro Blood–Brain Barrier Model for the High-Throughput Screening of Compounds in the Early Stage of Drug Discovery

Central nervous system (CNS) diseases are one of the top causes of death worldwide. As there is a difficulty of drug penetration into the brain due to the blood–brain barrier (BBB), many CNS drugs treatments fail in clinical trials. Hence, there is a need to develop effective CNS drugs following str...

Descripción completa

Detalles Bibliográficos
Autores principales: Moya, Elisa L. J., Vandenhaute, Elodie, Rizzi, Eleonora, Boucau, Marie-Christine, Hachani, Johan, Maubon, Nathalie, Gosselet, Fabien, Dehouck, Marie-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233835/
https://www.ncbi.nlm.nih.gov/pubmed/34208550
http://dx.doi.org/10.3390/pharmaceutics13060892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233835/
https://www.ncbi.nlm.nih.gov/pubmed/34208550
http://dx.doi.org/10.3390/pharmaceutics13060892

Ejemplares similares